New Pharmaceutical Marketing and Strategy in Opinion Leadership July 20, 2011

Massive changes have occurred over the last decade in the pharmaceutical industry and have consequently led to a period of transition, which has necessitated a change in approach. The previous blockbuster model was showing cracks, and reps were no longer seen as the solution to a lot of problems. SMi’s CPD accredited Masterclass gives industry professionals an insight into the inner workings of pharmaceutical marketing and enables delegates to develop an in-depth understanding of the role that opinion leaders in the new pharmaceutical industry environment.

Benefits of attending:

• Acquire an understanding of the role that opinion leaders have in the new pharmaceutical industry environment
• Gain an insight into the specific workings of pharmaceutical marketing
• Examine why the old pharmaceutical marketing was never really the answer and how the latest methods in pharmaceutical marketing are relevant in the new environment
• Discuss the adaptations needed to survive in the new pharmaceutical marketing domain e.g. changes in understanding of opinion leadership and how to implement an opinion leader strategy
• Assess the role of opinion leaders in the prevention of product discontinuance
• Learn from extremely experienced lecturers with decades of experience a wide range of areas within the Pharmaceutical sector

Join industry professionals at SMi's CPD accredited New Pharmaceutical Marketing and Strategy in Opinion Leadership on 20th July 2011, Central London, UK and learn how to overcome challenges pharmaceuticals face in marketing and how to key influence opinion leaders.

For further information and the opportunity to register, please visit the website. Alternatively, contact Mo Saffaf via Email: msaffaf@smi-online.co.uk or Tel: +44 (0) 20 7827 6022

Official Website: http://www.smi-online.co.uk/2011pharmamarketing25.asp